STOCK TITAN

SNEX (SNEX) investor files to sell 95,970 common shares via Merrill Lynch

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SNEX reports a planned sale of 95,970 shares of common stock, identified as related to Stock Plan Activity, with an anticipated sale date of July 22, 2026. The shares are to be sold through Merrill Lynch and are listed on NASDAQ. In addition, a holder named William Dunaway reports sales during the prior three months of 63,602 common shares on June 12, 2026 and 64,017 common shares on May 15, 2026.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 95,970 shares of common stock Securities to be sold, associated with Stock Plan Activity, dated 07/22/2026
Prior sale on June 12, 2026 63,602 shares of common stock Securities sold during the past 3 months by William Dunaway on 06/12/2026
Prior sale on May 15, 2026 64,017 shares of common stock Securities sold during the past 3 months by William Dunaway on 05/15/2026
Planned sale date 07/22/2026 Anticipated transaction date for sale of 95,970 common shares
Form 144 regulatory
"144: Securities To Be Sold Common | 07/22/2026 | Stock Plan Activity"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Plan Activity financial
"Common | 07/22/2026 | Stock Plan Activity | Issuer"
Securities sold during the past 3 months regulatory
"144: Securities Sold During The Past 3 Months William Dunaway"
Common financial
"Common | Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the SNEX Form 144 filing disclose?

The filing discloses a planned sale of 95,970 shares of SNEX common stock associated with Stock Plan Activity. The shares are expected to be sold through Merrill Lynch and are listed on NASDAQ, with an anticipated transaction date of July 22, 2026.

How many SNEX shares are proposed to be sold under this Form 144?

The Form 144 indicates a proposed sale of 95,970 shares of SNEX common stock. These shares are linked to Stock Plan Activity and are scheduled for potential sale on or around July 22, 2026 through Merrill Lynch on NASDAQ.

Which broker is handling the planned SNEX stock sale in this Form 144?

The proposed SNEX stock sale is to be handled by Merrill Lynch. The filing ties Merrill Lynch to the 95,970 common shares planned for sale, which are listed on NASDAQ with an anticipated sale date of July 22, 2026.

What recent sales of SNEX shares are reported for the past three months?

The filing lists sales by William Dunaway of 63,602 SNEX common shares on June 12, 2026 and 64,017 common shares on May 15, 2026. These transactions are reported as prior three‑month activity in connection with this notice.

Who is the selling security holder named in the SNEX Form 144?

The selling security holder referenced for recent activity is William Dunaway, with an address at 230 Park Ave, 10th Floor, New York, NY 10169. He reports prior sales of 63,602 and 64,017 SNEX common shares in the last three months.

On what date are the 95,970 SNEX shares expected to be sold?

The proposed sale date for the 95,970 SNEX common shares is July 22, 2026. This date appears both in the securities information and in the securities-to-be-sold section, tying the stock plan-related sale to that specific trading date on NASDAQ.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature